Wave Life Sciences, Inc. (WVE) › Operating IncomeWave Life Sciences, Inc. (WVE) — Operating IncomeAnnual figures by period end, from SEC filings.2013-12-31: -$3.57M2014-12-31: -$5.39M2015-12-31: -$19.30M2016-12-31: -$55.72M2017-12-31: -$102.39M2018-12-31: -$159.52M2019-12-31: -$208.32M2020-12-31: -$153.38M2021-12-31: -$127.02M2022-12-31: -$162.72M2023-12-31: -$68.00M2024-12-31: -$110.40M2025-12-31: -$215.38M-$215.38M2013-12-31Operating Income (USD)2025-12-31Period endedOperating IncomeChange YoYSource filing2025-12-31-$215.38M—2026-02-26From 2025-01-012024-12-31-$110.40M—2026-02-26From 2024-01-012023-12-31-$68.00M—2026-02-26From 2023-01-012022-12-31-$162.72M—2025-03-04From 2022-01-012021-12-31-$127.02M—2023-03-23From 2021-01-012020-12-31-$153.38M—2022-03-03From 2020-01-012019-12-31-$208.32M—2021-03-04From 2019-01-012018-12-31-$159.52M—2020-03-02From 2018-01-012017-12-31-$102.39M—2020-03-02From 2017-01-012016-12-31-$55.72M—2019-03-01From 2016-01-012015-12-31-$19.30M—2018-03-12From 2015-01-012014-12-31-$5.39M—2017-03-16From 2014-01-012013-12-31-$3.57M—2016-03-30From 2013-01-01Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)